Neuberger Berman Group’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Other funds holding XENT
VI
MF
FLAM
AAM
KLCMU
RSCM
Neuberger Berman Group's XENT Position: Q4 2021 in Review
Neuberger Berman Group sold out of Intersect ENT, Inc (XENT) in Q4 2021, closing a stake of 604,219 shares — an estimated $16.1M sold.
Neuberger Berman Group first reported a position in XENT in Q2 2015 and held it in 22 quarters. The position peaked at $25M in Q3 2017. 121 funds tracked by Wall St. Rank hold XENT as of Q4 2021.
- Neuberger Berman Group reported no remaining Intersect ENT, Inc position as of Q4 2021 after selling out during the quarter.
- Neuberger Berman Group sold 604,219 Intersect ENT, Inc shares in Q4 2021, an estimated $16.1M.
- Neuberger Berman Group first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 22 quarters.
- Neuberger Berman Group's Intersect ENT, Inc position peaked at $25M in Q3 2017.
- 121 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2021.
Based on Neuberger Berman Group's 13F filing for Q4 2021, filed 11 Feb 2022.